公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2012 | Primary squamous cell carcinoma of the thyroid with cardiac metastases and right ventricle outflow tract obstruction | KUO-HSING CHEN ; Chou Y.-H.; ANN-LII CHENG | Journal of Clinical Oncology | 14 | 12 | |
1995 | Primary T cell leptomeningeal lymphoma – Successful treatment with systemic chemotherapy | KUN-HUEI YEH ; ANN-LII CHENG ; HWEI-FANG TIEN | Oncology (Switzerland) | 14 | 9 | |
2006 | Primary thyroid lymphoma mimicking subacute thyroiditis [4] | Yang Y.-S.; MU-ZON WU ; ANN-LII CHENG ; TIEN-CHUN CHANG | Acta Cytologica | 9 | ||
2016 | Primary tumor site is a useful predictor of cetuximab efficacy in the third-line or salvage treatment of KRAS wild-type (exon 2 non-mutant) metastatic colorectal cancer: A nationwide cohort study | KUO-HSING CHEN ; YU-YUN SHAO ; Chen H.-M.; Lin Y.-L.; ZHONG-ZHE LIN ; Lai M.-S.; ANN-LII CHENG ; KUN-HUEI YEH | BMC Cancer | 39 | 39 | |
2022 | Prognosis and treatment pattern of advanced hepatocellular carcinoma after failure of first-line atezolizumab and bevacizumab treatment | Chen, Ching-Tso; Feng, Yin-Hsun; Yen, Chia-Jui; Chen, San-Chi; Lin, Yun-Tzu; LI-CHUN LU ; CHIH-HUNG HSU ; ANN-LII CHENG ; YU-YUN SHAO | Hepatology international | 14 | 14 | |
2012 | Prognosis of advanced hepatocellular carcinoma patients enrolled in clinical trials can be classified by current staging systems | YU-YUN SHAO ; LI-CHUN LU ; ZHONG-ZHE LIN ; CHIUN HSU ; Ying-Chun Shen ; CHIH-HUNG HSU ; ANN-LII CHENG | British Journal of Cancer | 26 | 26 | |
2014 | Prognosis of patients with advanced hepatocellular carcinoma who failed first-line systemic therapy | YU-YUN SHAO ; CHIH-HORNG WU ; LI-CHUN LU ; Chan S.-Y.; Ma Y.-Y.; Yen F.-C.; CHIH-HUNG HSU ; ANN-LII CHENG | Journal of Hepatology | 45 | 48 | |
2017 | Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies | Bruix J.; ANN-LII CHENG ; Meinhardt G.; Nakajima K.; De Sanctis Y.; Llovet J. | Journal of Hepatology | 412 | 402 | |
2007 | Prognostic Factors for Metastatic Urothelial Carcinoma Treated with Cisplatin and 5-Fluorouracil-Based Regimens | CHIA-CHI LIN ; CHIH-HUNG HSU ; CHAO-YUAN HUANG ; YU-CHIEH TSAI ; KUO-HOW HUANG ; ANN-LII CHENG ; YEONG-SHIAU PU | Urology | 24 | 21 | |
2008 | Prognostic factors in extrapulmonary small cell carcinomas: A large retrospective study | Lin Y.-L.; Chung C.-Y.; Chang C.-S.; Wu J.-S.; KUAN-TING KUO ; SUNG-HSIN KUO ; ANN-LII CHENG | Oncology | 20 | 17 | |
2013 | Prognostic factors of metastatic or recurrent esophageal squamous cell carcinoma in patients receiving three-drug combination chemotherapy | WEI-WU CHEN ; CHIA-CHI LIN ; TA-CHEN HUANG ; ANN-LII CHENG ; KUN-HUEI YEH ; CHIH-HUNG HSU | Anticancer Research | 11 | 11 | |
2015 | The prognostic impact of type 2 diabetes mellitus on early cervical cancer in Asia | HUNG-YANG KUO ; ZHONG-ZHE LIN ; Kuo R.; Shau W.-Y.; Lai C.-L.; Yang Y.-Y.; YU-YUN SHAO ; CHIUN HSU ; WEN-FANG CHENG ; ANN-LII CHENG ; CHIH-HSIN YANG ; Lai M.-S. | Oncologist | 10 | 10 | |
2011 | Prognostic molecular markers in Women aged 35 years or younger with breast cancer: Is there a difference from the older patients? | CHING-HUNG LIN ; YEN-SHEN LU ; CHIUN-SHENG HUANG ; KUAN-TING KUO ; Wang C.-C.; You S.-L.; PO-HAN LIN ; DWANG-YING CHANG ; WEN-HUNG KUO ; KING-JEN CHANG ; ANN-LII CHENG | Journal of Clinical Pathology | 8 | 8 | |
1997 | Prognostic significance of immunophenotypes in adult lymphoblastic lymphomas | KUN-HUEI YEH ; ANN-LII CHENG ; Su I.H.-J.; Lin M.-T.; HWEI-FANG TIEN ; MING-CHING SHEN ; Wang C.-H.; YAO-CHANG CHEN | Anticancer Research | 20 | 14 | |
2018 | Prognostic significance of tumor-infiltrating lymphocytes in patients with operable tongue cancer | WAN-YU CHEN ; CHEN-TU WU ; CHUN-WEI WANG ; KENG-HSUEH LAN ; HSIANG-KUANG LIANG ; Huang B.-S.; YIH-LEONG CHANG ; SUNG-HSIN KUO ; ANN-LII CHENG | Radiation Oncology | 25 | 25 | |
2002 | Prognostic value of multidrug resistance 1, glutathione-S-transferase-π and p53 in advanced nasopharyngeal carcinoma treated with systemic chemotherapy | CHIH-HUNG HSU ; Chen C.-L.; RUEY-LONG HONG ; Chen K.-L.; Lin J.-F.; ANN-LII CHENG | Oncology | 31 | 25 | |
2022 | Prognostic value of PD-L1 expression on immune cells or tumor cells for locally advanced esophageal squamous cell carcinoma in patients treated with neoadjuvant chemoradiotherapy | TA-CHEN HUANG ; Liang C.-W.; Li Y.-I.; GUO, JHE-CYUAN ; CHIA-CHI LIN ; Chen Y.-J.; ANN-LII CHENG ; CHIH-HUNG HSU | Journal of Cancer Research and Clinical Oncology | 2 | 2 | |
2000 | Prolonged and enhanced suppression of thymidylate synthase by weekly 24-h infusion of high-dose 5-fluorouracil | KUN-HUEI YEH ; Shiou-Hwei Yeh ; CHIH-HUNG HSU ; TONG-MEI WANG ; Ma I.-F.; ANN-LII CHENG | British Journal of Cancer | 26 | ||
2004 | Promoter polymorphisms of tumor necrosis factor-α are associated with risk of gastric mucosa-associated lymphoid tissue lymphoma | MING-SHIANG WU ; Chen L.-T.; CHIA-TUNG SHUN ; Huang S.-P.; HAN-MO CHIU ; HSIU-PO WANG ; MING-TSAN LIN ; ANN-LII CHENG ; Lin J.-T. | International Journal of Cancer | 60 | 54 | |
2001 | Prospective study of Helicobacter pylori eradication therapy in stage IE high-grade mucosa-associated lymphoid tissue lymphoma of the stomach | Chen L.-T.; Lin J.-T.; Shyu R.-Y.; Jan C.-M.; Chen C.-L.; Chiang I.-P.; Liu S.-M.; Su I.-J.; ANN-LII CHENG | Journal of Clinical Oncology | 95 | 76 |